Disruptive Technology Content Hub Power of Precision Medicine Could be Fueled Here By Tom LydonMay 22, 2020
Disruptive Technology Content Hub Genomics ETF Setting Up Nicely for the Long-Term By Tom LydonMay 18, 2020
Disruptive Technology Content Hub Genomic Stocks Are in the First Inning of a Multi-Year Megatrend By Special To VettaFiMay 16, 2020
Disruptive Technology Content Hub Why ETF Investors Should Consider Allocating to Innovation By Max ChenMay 14, 2020
Disruptive Technology Content Hub Making the Case for Innovation: Rethinking Traditional Asset Allocation By Max ChenMay 13, 2020
Disruptive Technology Content Hub Virus Detection Is Just One Catalyst for This Hot Genomics ETF By Tom LydonMay 5, 2020
Disruptive Technology Content Hub ETF of the Week: ARKG, the ARK Genomic Revolution Multi-Sector Fund By Aaron NeuwirthApril 30, 2020
Disruptive Technology Content Hub This Biotechnology ETF Could Be the Place to Be in a Recession By Tom LydonApril 27, 2020
Disruptive Technology Content Hub This Genomics ETF Is up to Its Old Tricks and That’s Great For Investors By Tom LydonApril 20, 2020
Disruptive Technology Content Hub This ETF Welcomes Investors to the Next Generation of Healthcare By Tom LydonApril 1, 2020
Disruptive Technology Content Hub A Q&A with Trusted Experts to Help Clarify the Uncertainty By Max ChenMarch 26, 2020
Disruptive Technology Content Hub How to View Assets and Liabilities in the Genomics Space By Tom LydonMarch 25, 2020
Disruptive Technology Content Hub This Genomics ETF’s Holdings Can Ward Off Chinese Competition By Tom LydonMarch 3, 2020
Disruptive Technology Content Hub ETFs to Tap into Disruptive Technologies That Can Revolutionize the World By Max ChenMarch 2, 2020
